Supergut secures major investment and appoints former Vital Proteins CEO to head next growth phase

Supergut, a leading gut health and GLP-1 nutrition brand, has closed a significant minority growth investment. As part of this new chapter, industry veteran Tracey Warner Halama, former CEO of Vital Proteins, will join Supergut as its new CEO.

Over the past year, Supergut has experienced 172% growth, expanding its retail presence to more than 5,000 brick-and-mortar stores, including Erewhon, Target, Sprouts, GNC, and Vitamin Shoppe.

Offering prebiotic bars and shakes, the company attributes strong momentum to its GLP-1 booster product, an unflavored powder containing 6 g of a patented prebiotic fiber blend per serving, which can be mixed into any food or beverage.

Supergut communicates that its products have been clinically proven to control cravings, support gut health, reduce blood sugar levels, and sustain energy levels.

“Supergut has always been about more than just products — I founded the company in my sister’s memory to empower people to take control of their health through the science of the gut microbiome,” says company founder Marc Washington.

“I’m excited to partner with Tracey in bringing her proven leadership and experience building iconic wellness brands to amplify our bold mission. In addition, Bader has helped shepherd several successful consumer investments over the last decade, and I’m thrilled to have him join as our lead investor in this round.”

Expanding in retail with new product development

With this investment, Supergut aims to drive product innovation and expand into new retail placements.

The funding round was led by Full Frame Growth Partners, an Austin-based growth equity firm known for supporting high-potential consumer brands.

Full Frame’s founder and managing partner, Bader Alam, will join Supergut’s board of directors. Washington will transition to the role of executive chairman, focusing on strategic expansion and science-backed innovation.

Warner Halama, a seasoned CPG executive, will leverage her experience from scaling Vital Proteins from inception to acquisition by Nestlé Health Science in her new leadership role at Supergut.

“Supergut has all the makings to create a legacy brand; a science foundation that legitimizes the prebiotic, fiber-rich supplement; growing brand awareness with national distribution at leading retailers; and mission-driven purpose,” comments Halama.

“Adding the strong tailwinds of both GLP-1 and fiber as categories, Supergut is well poised for exceptional growth in the coming years, and I’m honored to lead the next chapter.”

Bader Alam, founder and managing partner of Full Frame Growth Partners, adds: “Gut health and GLP-1 nutrition are two consumer megatrends that continue to gain traction. Supergut is at the forefront of these movements with a leading brand and accessible products powered by prebiotic fiber that can easily fit into one’s daily routine.”

Other investors include Supergut founding investor Dave Friedberg via The Production Board, as well as Cultivian Sandbox, Strand Equity, Access Capital, Alpha Edison, LivWell Ventures, and Rocana Ventures.

Gut health advances

In recent funding advances, the dsm-firmenich’s inaugural Nutrition Research Grant earmarked five distinguished researchers from the Asia-Pacific region to each be awarded €50,000 (US$52,695) to support up to 18 months of research to advance scientific understanding of gut health.

Meanwhile, scientists in the EU outlined a new strategic roadmap for prebiotic health claims to gain regulatory recognition in food and supplements. Currently, the term prebiotics has not been authorized in the region for use as a health claim, nor are there recommendations on how to achieve this.

In a Nutrition Insight webinar, “From discomfort to wellness: Consumer voices and probiotic science in gut health,” Novonesis dived into the latest gut health market trends, consumer insights, and clinically studied probiotics, stressing the importance of the gut microbiome beyond digestive health.